ホーム>>Signaling Pathways>> Chromatin/Epigenetics>> Citrullination>>Citrulline-specific Probe-Rhodamine

Citrulline-specific Probe-Rhodamine (Synonyms: Rhodamine Phenylglyoxal, RhPG)

カタログ番号GC43275

タンパク質アルギニンディミナーゼ(PAD)は、タンパク質上のアルギニン残基をシトルリンに変換する後翻訳修飾を触媒し、遺伝子発現の調節に大きな役割を果たします。

Products are for research use only. Not for human use. We do not sell to patients.

Citrulline-specific Probe-Rhodamine 化学構造

Cas No.: 2309313-01-5

サイズ 価格 在庫数 個数
250μg
$238.00
在庫あり
500μg
$428.00
在庫あり
1mg
$762.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Protein arginine deiminases (PADs) catalyze the posttranslational modification of arginine residues on proteins to form citrulline, which plays a large role in regulating gene expression. Abnormally high PAD activity has been observed in a host of human diseases. Citrulline-specific probe-rhodamine is a highly sensitive, rhodamine phenylglyoxal-based fluorophore that specifically detects protein citrullination via a chemoselective reaction between glyoxal and citrulline. This chemical probe (comprised of a single isomer) is capable of reacting with any citrulline-containing protein and can be analyzed with fluorescent imaging (excitation 532 nm; emission 580 nm). When added at 100 µM for 30 minutes at acidic pH, this probe has a reported limit of detection of ~10 ng for citrullinated histone H3 and ~1 ng for autodeiminated PAD4.

レビュー

Review for Citrulline-specific Probe-Rhodamine

Average Rating: 5 ★★★★★ (Based on Reviews and 1 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Citrulline-specific Probe-Rhodamine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.